Literature DB >> 27073049

A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis.

Justin Davis1, Harris Eyre2, Felice N Jacka3, Seetal Dodd4, Olivia Dean4, Sarah McEwen5, Monojit Debnath6, John McGrath7, Michael Maes2, Paul Amminger8, Patrick D McGorry9, Christos Pantelis10, Michael Berk11.   

Abstract

Schizophrenia risk has often been conceptualized using a model which requires two hits in order to generate the clinical phenotype-the first as an early priming in a genetically predisposed individual and the second a likely environmental insult. The aim of this paper was to review the literature and reformulate this binary risk-vulnerability model. We sourced the data for this narrative review from the electronic database PUBMED. Our search terms were not limited by language or date of publication. The development of schizophrenia may be driven by genetic vulnerability interacting with multiple vulnerability factors including lowered prenatal vitamin D exposure, viral infections, smoking intelligence quotient, social cognition cannabis use, social defeat, nutrition and childhood trauma. It is likely that these genetic risks, environmental risks and vulnerability factors are cumulative and interactive with each other and with critical periods of neurodevelopmental vulnerability. The development of schizophrenia is likely to be more complex and nuanced than the binary two hit model originally proposed nearly thirty years ago. Risk appears influenced by a more complex process involving genetic risk interfacing with multiple potentially interacting hits and vulnerability factors occurring at key periods of neurodevelopmental activity, which culminate in the expression of disease state. These risks are common across a number of neuropsychiatric and medical disorders, which might inform common preventive and intervention strategies across non-communicable disorders.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27073049      PMCID: PMC4876729          DOI: 10.1016/j.neubiorev.2016.03.017

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  130 in total

Review 1.  Developmental vitamin D deficiency and risk of schizophrenia: a 10-year update.

Authors:  John J McGrath; Thomas H Burne; François Féron; Allan Mackay-Sim; Darryl W Eyles
Journal:  Schizophr Bull       Date:  2010-09-10       Impact factor: 9.306

Review 2.  The prevention of schizophrenia.

Authors:  Alan S Brown; John J McGrath
Journal:  Schizophr Bull       Date:  2010-10-27       Impact factor: 9.306

Review 3.  Perinatal Risks and Childhood Premorbid Indicators of Later Psychosis: Next Steps for Early Psychosocial Interventions.

Authors:  Cindy H Liu; Matcheri S Keshavan; Ed Tronick; Larry J Seidman
Journal:  Schizophr Bull       Date:  2015-04-22       Impact factor: 9.306

Review 4.  Stress, the hippocampus and the hypothalamic-pituitary-adrenal axis: implications for the development of psychotic disorders.

Authors:  Lisa J Phillips; Patrick D McGorry; Belinda Garner; Katherine N Thompson; Christos Pantelis; Stephen J Wood; Gregor Berger
Journal:  Aust N Z J Psychiatry       Date:  2006-09       Impact factor: 5.744

Review 5.  The functional significance of social cognition in schizophrenia: a review.

Authors:  Shannon M Couture; David L Penn; David L Roberts
Journal:  Schizophr Bull       Date:  2006-08-17       Impact factor: 9.306

Review 6.  Infectious agents associated with schizophrenia: a meta-analysis.

Authors:  Isabel Arias; Antonio Sorlozano; Enrique Villegas; Juan de Dios Luna; Kathryn McKenney; Jorge Cervilla; Blanca Gutierrez; Jose Gutierrez
Journal:  Schizophr Res       Date:  2011-11-21       Impact factor: 4.939

Review 7.  Stress and trauma: BDNF control of dendritic-spine formation and regression.

Authors:  M R Bennett; J Lagopoulos
Journal:  Prog Neurobiol       Date:  2013-11-06       Impact factor: 11.685

8.  Cannabis use, gender and age of onset of schizophrenia: data from the ÆSOP study.

Authors:  Kim Donoghue; Gillian A Doody; Robin M Murray; Peter B Jones; Craig Morgan; Paola Dazzan; Jozella Hart; Rodolfo Mazzoncini; James H Maccabe
Journal:  Psychiatry Res       Date:  2014-01-04       Impact factor: 3.222

Review 9.  Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia.

Authors:  Shitij Kapur
Journal:  Am J Psychiatry       Date:  2003-01       Impact factor: 18.112

10.  A Rosetta stone for epidemiology: genomic risk profile scores contain clues related to modifiable risk factors.

Authors:  John J McGrath
Journal:  Epidemiol Psychiatr Sci       Date:  2014-10-23       Impact factor: 6.892

View more
  78 in total

1.  A comparison of regional brain volumes and white matter connectivity in subjects with stimulant induced psychosis versus schizophrenia.

Authors:  Peter D Alexander; Kristina M Gicas; Alex Cheng; Donna J Lang; Ric M Procyshyn; Alexandra T Vertinsky; William J Panenka; Allen E Thornton; Alexander Rauscher; Jamie Y X Wong; Tasha Chan; Andrea A Jones; F Vila-Rodriguez; William G Honer; Alasdair M Barr
Journal:  Psychopharmacology (Berl)       Date:  2019-06-22       Impact factor: 4.530

Review 2.  Microglial memory of early life stress and inflammation: Susceptibility to neurodegeneration in adulthood.

Authors:  Paula Desplats; Ashley M Gutierrez; Marta C Antonelli; Martin G Frasch
Journal:  Neurosci Biobehav Rev       Date:  2019-11-05       Impact factor: 8.989

3.  Deficit, but Not Nondeficit, Schizophrenia Is Characterized by Mucosa-Associated Activation of the Tryptophan Catabolite (TRYCAT) Pathway with Highly Specific Increases in IgA Responses Directed to Picolinic, Xanthurenic, and Quinolinic Acid.

Authors:  Buranee Kanchanatawan; Sunee Sirivichayakul; Kiat Ruxrungtham; André F Carvalho; Michel Geffard; Heidi Ormstad; George Anderson; Michael Maes
Journal:  Mol Neurobiol       Date:  2017-02-08       Impact factor: 5.590

4.  Childhood temperament is associated with distress, anxiety and reduced quality of life in schizophrenia spectrum disorders.

Authors:  Brandee Feola; Kristan Armstrong; Neil D Woodward; Stephan Heckers; Jennifer Urbano Blackford
Journal:  Psychiatry Res       Date:  2019-03-11       Impact factor: 3.222

5.  Staging in bipolar disorder: from theoretical framework to clinical utility.

Authors:  Michael Berk; Robert Post; Aswin Ratheesh; Emma Gliddon; Ajeet Singh; Eduard Vieta; Andre F Carvalho; Melanie M Ashton; Lesley Berk; Susan M Cotton; Patrick D McGorry; Brisa S Fernandes; Lakshmi N Yatham; Seetal Dodd
Journal:  World Psychiatry       Date:  2017-10       Impact factor: 49.548

Review 6.  Sensorimotor gating deficits in "two-hit" models of schizophrenia risk factors.

Authors:  Asma Khan; Susan B Powell
Journal:  Schizophr Res       Date:  2017-10-22       Impact factor: 4.939

7.  Changes in Tryptophan Catabolite (TRYCAT) Pathway Patterning Are Associated with Mild Impairments in Declarative Memory in Schizophrenia and Deficits in Semantic and Episodic Memory Coupled with Increased False-Memory Creation in Deficit Schizophrenia.

Authors:  Buranee Kanchanatawan; Solaphat Hemrungrojn; Supaksorn Thika; Sunee Sirivichayakul; Kiat Ruxrungtham; André F Carvalho; Michel Geffard; George Anderson; Michael Maes
Journal:  Mol Neurobiol       Date:  2017-09-05       Impact factor: 5.590

8.  In Schizophrenia, Deficits in Natural IgM Isotype Antibodies Including those Directed to Malondialdehyde and Azelaic Acid Strongly Predict Negative Symptoms, Neurocognitive Impairments, and the Deficit Syndrome.

Authors:  Michael Maes; Buranee Kanchanatawan; Sunee Sirivichayakul; André F Carvalho
Journal:  Mol Neurobiol       Date:  2018-11-27       Impact factor: 5.590

9.  Prenatal kynurenine exposure in rats: age-dependent changes in NMDA receptor expression and conditioned fear responding.

Authors:  Michelle L Pershing; David Phenis; Valentina Valentini; Ana Pocivavsek; Derick H Lindquist; Robert Schwarcz; John P Bruno
Journal:  Psychopharmacology (Berl)       Date:  2016-08-16       Impact factor: 4.530

10.  N-acetyl cysteine reverses bio-behavioural changes induced by prenatal inflammation, adolescent methamphetamine exposure and combined challenges.

Authors:  Twanette Swanepoel; Marisa Möller; Brian Herbert Harvey
Journal:  Psychopharmacology (Berl)       Date:  2017-11-08       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.